Skip to main content
. 2024 Dec 12;272(1):11. doi: 10.1007/s00415-024-12804-4

Table 3.

Comparison of de novo PD with postural instability and gait (PIGD) subtype vs de novo PD with non-PIGD subtype

De novo PIGD PD
N = 10
De novo non-PIGD PD
N = 37
p value
Age (years) 69 (5.0; 64–78) 66 (11.7; 45–83)d 0.582d
Female gender 4 (40) 14 (38) 0.999c
Disease severity (HY)a III (II–III; II–III) II (II–II; I–III) 0.001e
Cognition (MOCA)b 24.5 (23–27; 21–29) 26 (24–28; 17–30) 0.487e
Executive function (FAB)b 14.5 (11–17; 9–17) 16 (15–17; 3–18) 0.241e
Motor symptoms (UPDRS)a 26 (21–34; 13–42) 18 (14–25; 8–53) 0.049e
Reactive balance (NRT)a 2 (0–2; 0–2) 0 (0–0; 0–2)  < 0.001e
Dynamic balance (TG)a 3 (1–3; 0–3) 0 (0–1; 0–3) 0.003e
Mobility (TUG), sa 10.8 (10.3–12.0; 7.3–15.0) 8.9 (7.6–10.5; 6.4–19.1) 0.013e
Dual tasking difficulties 4 (44) n=9 9 (26) n=35 0.272c
CGS (10MWT), m/sb 1.0 (0.9–1.0; 0.6–1.1) 1.2 (0.9–1.4; 0.5–1.6) 0.009e
FGS (10MWT), m/sb 1.3 (1.3–1.6; 0.8–1.7) 1.7 (1.4–2.1; 0.7–3.1) 0.020e
FOG (FOGQsa item 3)a 0 (0–4; 0–4) 0 (0–0; 0–2) 0.002e
Walking ability (Walk12G)a 17.5 (13–20; 8–30) 4 (1–12; 0–33)  < 0.001e
Number of individuals with one or more prospective falls 2 (20) 2 (5) 0.142c
Number of individuals with one or more prospective near falls 1 (10) 3 (8) 0.849c

Values are mean (SD; min–max), median (q1–q3; min–max) or n (%). Significant p-values are indicated in bold

CGS comfortable gait speed, FAB frontal assessment battery, FGS Fast Gait speed, FOGQsa Freezing of Gait Questionnaire self-administered version, H&Y Hoehn and Yahr stage, MOCA Montreal Cognitive Assessment, NRT Nutt Retropulsion Test, UPDRS Unified Parkinson’s Disease Rating Scale, 10MWT 10-Meter Walk Test, m/s meters per second, TG Tandem Gait, TUG Timed Up and Go, Walk–12G 12-item generic walking scale

aHigher = worse

bHigher = better

cChi–test

dStudent's T test

eMann–Whitney U test